PDB Short entry for 3B95 HEADER TRANSFERASE/STRUCTURAL PROTEIN 02-NOV-07 3B95 TITLE EUHMT1 (GLP) ANKYRIN REPEAT DOMAIN (STRUCTURE 2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: EUCHROMATIC HISTONE-LYSINE N-METHYLTRANSFERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ANKYRIN REPEAT DOMAINS; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HISTONE H3 N-TERMINAL PEPTIDE; COMPND 8 CHAIN: P; COMPND 9 FRAGMENT: H3 AMINO TERMINUS PEPTIDE; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EHMT1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODON PLUS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES KEYWDS ANKYRIN REPEAT, ANK REPEAT, METHYLTRANSFERASE, TRANSFERASE, KEYWDS 2 TRANSFERASE-STRUCTURAL PROTEIN COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.E.COLLINS,J.R.HORTON,X.CHENG REVDAT 5 30-AUG-23 3B95 1 REMARK LINK REVDAT 4 01-FEB-12 3B95 1 REMARK VERSN REVDAT 3 24-FEB-09 3B95 1 VERSN REVDAT 2 18-MAR-08 3B95 1 JRNL REVDAT 1 12-FEB-08 3B95 0 JRNL AUTH R.E.COLLINS,J.P.NORTHROP,J.R.HORTON,D.Y.LEE,X.ZHANG, JRNL AUTH 2 M.R.STALLCUP,X.CHENG JRNL TITL THE ANKYRIN REPEATS OF G9A AND GLP HISTONE JRNL TITL 2 METHYLTRANSFERASES ARE MONO- AND DIMETHYLLYSINE BINDING JRNL TITL 3 MODULES. JRNL REF NAT.STRUCT.MOL.BIOL. V. 15 245 2008 JRNL REFN ISSN 1545-9993 JRNL PMID 18264113 JRNL DOI 10.1038/NSMB.1384 REMARK 2 REMARK 2 RESOLUTION. 2.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 15329 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 742 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.99 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.10 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3460 REMARK 3 BIN FREE R VALUE : 0.3850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 67 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.047 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3545 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 28 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.54000 REMARK 3 B22 (A**2) : -2.10000 REMARK 3 B33 (A**2) : -3.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 24.9 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.980 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3B95 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000045234. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : SI (220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15898 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.990 REMARK 200 RESOLUTION RANGE LOW (A) : 24.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.20 REMARK 200 R MERGE (I) : 0.15000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 11.50 REMARK 200 R MERGE FOR SHELL (I) : 0.69700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: GLRF REMARK 200 STARTING MODEL: PDB: 3B7B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5-2.0 M LITHIUM SULFATE; 1-4% PEG REMARK 280 400 OR 550; 0.1 M TRIS BUFFER PH=8.5 , VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 289K, PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.66000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 83.66000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.76000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 76.19500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.76000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 76.19500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 83.66000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.76000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 76.19500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 83.66000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.76000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 76.19500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS TWO MOLECULES (CHAIN ID A AND REMARK 300 B), OF WHICH ONE (CHAIN ID B) CONTAINS H3 PEPTIDE (CHAIN ID P). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 968 REMARK 465 HIS B -1 REMARK 465 MET B 0 REMARK 465 ASN B 734 REMARK 465 PHE B 735 REMARK 465 LYS B 736 REMARK 465 MET B 737 REMARK 465 GLU B 738 REMARK 465 HIS B 739 REMARK 465 GLN B 740 REMARK 465 ASN B 741 REMARK 465 LYS B 742 REMARK 465 ALA B 968 REMARK 465 LYS P 4 REMARK 465 GLN P 5 REMARK 465 THR P 6 REMARK 465 LYS P 14 REMARK 465 ALA P 15 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 739 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 741 CG OD1 ND2 REMARK 470 GLU A 892 CG CD OE1 OE2 REMARK 470 LYS A 898 CG CD CE NZ REMARK 470 LYS A 937 CG CD CE NZ REMARK 470 GLU A 940 CG CD OE1 OE2 REMARK 470 LYS A 962 CG CD CE NZ REMARK 470 GLN A 965 CG CD OE1 NE2 REMARK 470 ASP A 966 CG OD1 OD2 REMARK 470 SER A 967 OG REMARK 470 GLU B 773 CG CD OE1 OE2 REMARK 470 LYS B 796 CG CD CE NZ REMARK 470 LYS B 898 CG CD CE NZ REMARK 470 LYS B 962 CG CD CE NZ REMARK 470 LEU B 964 CG CD1 CD2 REMARK 470 GLN B 965 CG CD OE1 NE2 REMARK 470 ASP B 966 CG OD1 OD2 REMARK 470 SER B 967 OG REMARK 470 THR P 3 OG1 CG2 REMARK 470 ARG P 8 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 738 -74.92 -73.85 REMARK 500 HIS A 787 76.56 -106.63 REMARK 500 ALA A 797 -3.07 -166.85 REMARK 500 SER A 829 -88.36 -70.65 REMARK 500 SER A 863 3.67 -51.17 REMARK 500 ASN A 873 7.24 -64.64 REMARK 500 GLU A 875 -3.20 73.09 REMARK 500 ALA A 896 -9.74 -55.17 REMARK 500 TYR A 921 -79.47 -43.46 REMARK 500 ASP A 922 -37.21 -36.23 REMARK 500 ASP A 931 60.26 60.48 REMARK 500 ASP A 933 105.72 -58.74 REMARK 500 ASN A 938 -158.69 -106.95 REMARK 500 ASP B 805 -171.36 -61.44 REMARK 500 LYS B 898 60.99 63.99 REMARK 500 ILE B 906 0.61 -60.24 REMARK 500 ASN B 919 48.09 30.78 REMARK 500 LYS B 939 5.06 -55.22 REMARK 500 LEU B 964 -19.95 -42.85 REMARK 500 GLN B 965 -60.00 -90.93 REMARK 500 ASP B 966 24.66 -63.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 8 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 10 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 9 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3B7B RELATED DB: PDB REMARK 900 SAME PROTEIN WITHOUT PEPTIDE DBREF 3B95 A 734 968 UNP Q5VT56 Q5VT56_HUMAN 734 968 DBREF 3B95 B 734 968 UNP Q5VT56 Q5VT56_HUMAN 734 968 DBREF 3B95 P 1 15 PDB 3B95 3B95 1 15 SEQADV 3B95 HIS A -1 UNP Q5VT56 EXPRESSION TAG SEQADV 3B95 MET A 0 UNP Q5VT56 EXPRESSION TAG SEQADV 3B95 HIS B -1 UNP Q5VT56 EXPRESSION TAG SEQADV 3B95 MET B 0 UNP Q5VT56 EXPRESSION TAG SEQRES 1 A 237 HIS MET ASN PHE LYS MET GLU HIS GLN ASN LYS ARG SER SEQRES 2 A 237 PRO LEU HIS ALA ALA ALA GLU ALA GLY HIS VAL ASP ILE SEQRES 3 A 237 CYS HIS MET LEU VAL GLN ALA GLY ALA ASN ILE ASP THR SEQRES 4 A 237 CYS SER GLU ASP GLN ARG THR PRO LEU MET GLU ALA ALA SEQRES 5 A 237 GLU ASN ASN HIS LEU GLU ALA VAL LYS TYR LEU ILE LYS SEQRES 6 A 237 ALA GLY ALA LEU VAL ASP PRO LYS ASP ALA GLU GLY SER SEQRES 7 A 237 THR CYS LEU HIS LEU ALA ALA LYS LYS GLY HIS TYR GLU SEQRES 8 A 237 VAL VAL GLN TYR LEU LEU SER ASN GLY GLN MET ASP VAL SEQRES 9 A 237 ASN CYS GLN ASP ASP GLY GLY TRP THR PRO MET ILE TRP SEQRES 10 A 237 ALA THR GLU TYR LYS HIS VAL ASP LEU VAL LYS LEU LEU SEQRES 11 A 237 LEU SER LYS GLY SER ASP ILE ASN ILE ARG ASP ASN GLU SEQRES 12 A 237 GLU ASN ILE CYS LEU HIS TRP ALA ALA PHE SER GLY CYS SEQRES 13 A 237 VAL ASP ILE ALA GLU ILE LEU LEU ALA ALA LYS CYS ASP SEQRES 14 A 237 LEU HIS ALA VAL ASN ILE HIS GLY ASP SER PRO LEU HIS SEQRES 15 A 237 ILE ALA ALA ARG GLU ASN ARG TYR ASP CYS VAL VAL LEU SEQRES 16 A 237 PHE LEU SER ARG ASP SER ASP VAL THR LEU LYS ASN LYS SEQRES 17 A 237 GLU GLY GLU THR PRO LEU GLN CYS ALA SER LEU ASN SER SEQRES 18 A 237 GLN VAL TRP SER ALA LEU GLN MET SER LYS ALA LEU GLN SEQRES 19 A 237 ASP SER ALA SEQRES 1 B 237 HIS MET ASN PHE LYS MET GLU HIS GLN ASN LYS ARG SER SEQRES 2 B 237 PRO LEU HIS ALA ALA ALA GLU ALA GLY HIS VAL ASP ILE SEQRES 3 B 237 CYS HIS MET LEU VAL GLN ALA GLY ALA ASN ILE ASP THR SEQRES 4 B 237 CYS SER GLU ASP GLN ARG THR PRO LEU MET GLU ALA ALA SEQRES 5 B 237 GLU ASN ASN HIS LEU GLU ALA VAL LYS TYR LEU ILE LYS SEQRES 6 B 237 ALA GLY ALA LEU VAL ASP PRO LYS ASP ALA GLU GLY SER SEQRES 7 B 237 THR CYS LEU HIS LEU ALA ALA LYS LYS GLY HIS TYR GLU SEQRES 8 B 237 VAL VAL GLN TYR LEU LEU SER ASN GLY GLN MET ASP VAL SEQRES 9 B 237 ASN CYS GLN ASP ASP GLY GLY TRP THR PRO MET ILE TRP SEQRES 10 B 237 ALA THR GLU TYR LYS HIS VAL ASP LEU VAL LYS LEU LEU SEQRES 11 B 237 LEU SER LYS GLY SER ASP ILE ASN ILE ARG ASP ASN GLU SEQRES 12 B 237 GLU ASN ILE CYS LEU HIS TRP ALA ALA PHE SER GLY CYS SEQRES 13 B 237 VAL ASP ILE ALA GLU ILE LEU LEU ALA ALA LYS CYS ASP SEQRES 14 B 237 LEU HIS ALA VAL ASN ILE HIS GLY ASP SER PRO LEU HIS SEQRES 15 B 237 ILE ALA ALA ARG GLU ASN ARG TYR ASP CYS VAL VAL LEU SEQRES 16 B 237 PHE LEU SER ARG ASP SER ASP VAL THR LEU LYS ASN LYS SEQRES 17 B 237 GLU GLY GLU THR PRO LEU GLN CYS ALA SER LEU ASN SER SEQRES 18 B 237 GLN VAL TRP SER ALA LEU GLN MET SER LYS ALA LEU GLN SEQRES 19 B 237 ASP SER ALA SEQRES 1 P 15 ALA ARG THR LYS GLN THR ALA ARG MLY SER THR GLY GLY SEQRES 2 P 15 LYS ALA MODRES 3B95 MLY P 9 LYS N-DIMETHYL-LYSINE HET MLY P 9 11 HET SO4 A 5 5 HET SO4 A 6 5 HET SO4 A 7 5 HET SO4 A 8 5 HET SO4 A 10 5 HET SO4 B 1 5 HET SO4 B 2 5 HET SO4 B 3 5 HET SO4 B 4 5 HET SO4 B 9 5 HETNAM MLY N-DIMETHYL-LYSINE HETNAM SO4 SULFATE ION FORMUL 3 MLY C8 H18 N2 O2 FORMUL 4 SO4 10(O4 S 2-) FORMUL 14 HOH *28(H2 O) HELIX 1 1 SER A 744 GLY A 753 1 10 HELIX 2 2 HIS A 754 ALA A 764 1 11 HELIX 3 3 THR A 777 ASN A 785 1 9 HELIX 4 4 HIS A 787 LYS A 796 1 10 HELIX 5 5 THR A 810 LYS A 818 1 9 HELIX 6 6 HIS A 820 SER A 829 1 10 HELIX 7 7 THR A 844 TYR A 852 1 9 HELIX 8 8 HIS A 854 SER A 863 1 10 HELIX 9 9 ILE A 877 GLY A 886 1 10 HELIX 10 10 CYS A 887 ALA A 896 1 10 HELIX 11 11 SER A 910 GLU A 918 1 9 HELIX 12 12 ARG A 920 SER A 929 1 10 HELIX 13 13 THR A 943 ALA A 948 1 6 HELIX 14 14 SER A 952 SER A 967 1 16 HELIX 15 15 SER B 744 ALA B 752 1 9 HELIX 16 16 HIS B 754 GLY B 765 1 12 HELIX 17 17 THR B 777 ASN B 785 1 9 HELIX 18 18 HIS B 787 ALA B 797 1 11 HELIX 19 19 THR B 810 GLY B 819 1 10 HELIX 20 20 HIS B 820 LEU B 828 1 9 HELIX 21 21 THR B 844 TYR B 852 1 9 HELIX 22 22 HIS B 854 LYS B 864 1 11 HELIX 23 23 ILE B 877 GLY B 886 1 10 HELIX 24 24 CYS B 887 ALA B 897 1 11 HELIX 25 25 SER B 910 GLU B 918 1 9 HELIX 26 26 ARG B 920 ARG B 930 1 11 HELIX 27 27 SER B 952 ASP B 966 1 15 LINK C ARG P 8 N MLY P 9 1555 1555 1.33 LINK C MLY P 9 N SER P 10 1555 1555 1.33 SITE 1 AC1 5 ASN A 919 TYR A 921 ASP A 922 HOH A 981 SITE 2 AC1 5 HOH A 982 SITE 1 AC2 5 ASN A 786 GLY A 819 HIS A 820 TYR A 821 SITE 2 AC2 5 GLU A 822 SITE 1 AC3 4 LYS A 853 HIS A 854 VAL A 855 ASP A 856 SITE 1 AC4 5 ASN A 786 HIS A 787 LEU A 788 GLU A 789 SITE 2 AC4 5 HOH A 974 SITE 1 AC5 2 LYS A 792 LYS A 796 SITE 1 AC6 4 ASN B 919 TYR B 921 ASP B 922 HOH B 980 SITE 1 AC7 1 ARG B 920 SITE 1 AC8 6 ASN B 786 GLY B 819 HIS B 820 TYR B 821 SITE 2 AC8 6 GLU B 822 HOH B 979 SITE 1 AC9 4 GLY B 753 HIS B 754 VAL B 755 ASP B 756 SITE 1 BC1 4 LYS B 853 HIS B 854 VAL B 855 ASP B 856 CRYST1 59.520 152.390 167.320 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016807 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006562 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005977 0.00000